Impax Laboratories Enterprise Value:
913.02M for May 21, 2013Impax Laboratories Historical Enterprise Value Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | 913.02M |
| May 20, 2013 | 913.02M |
| May 17, 2013 | 912.34M |
| May 16, 2013 | 927.40M |
| May 15, 2013 | 882.89M |
| May 14, 2013 | 886.31M |
| May 13, 2013 | 869.19M |
| May 10, 2013 | 842.49M |
| May 9, 2013 | 756.89M |
| May 8, 2013 | 771.27M |
| May 7, 2013 | 770.59M |
| May 6, 2013 | 810.99M |
| May 3, 2013 | 815.10M |
| May 2, 2013 | 804.83M |
| May 1, 2013 | 840.43M |
| April 30, 2013 | 849.34M |
| April 29, 2013 | 852.08M |
| April 26, 2013 | 857.55M |
| April 25, 2013 | 848.22M |
| April 24, 2013 | 847.53M |
| April 23, 2013 | 858.49M |
| April 22, 2013 | 818.77M |
| April 19, 2013 | 796.85M |
| April 18, 2013 | 757.81M |
| April 17, 2013 | 757.12M |
| April 16, 2013 | 762.60M |
| April 15, 2013 | 753.01M |
| April 12, 2013 | 778.36M |
| April 11, 2013 | 781.10M |
| April 10, 2013 | 783.15M |
| April 9, 2013 | 747.53M |
| April 8, 2013 | 750.96M |
| April 5, 2013 | 765.34M |
| April 4, 2013 | 748.90M |
| April 3, 2013 | 740.00M |
| April 2, 2013 | 698.22M |
| April 1, 2013 | 698.22M |
| March 28, 2013 | 758.11M |
| March 27, 2013 | 756.74M |
| March 26, 2013 | 768.38M |
| March 25, 2013 | 759.48M |
| March 22, 2013 | 770.43M |
| March 21, 2013 | 765.64M |
| March 20, 2013 | 788.23M |
| March 19, 2013 | 767.01M |
| March 18, 2013 | 770.43M |
| March 15, 2013 | 780.70M |
| March 14, 2013 | 813.56M |
| March 13, 2013 | 821.78M |
| March 12, 2013 | 847.11M |
About Enterprise Value
Click "Learn More" below to see how YCharts calculates Enterprise Value.
Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More
IPXL Enterprise Value Benchmarks
| Companies | |
|---|---|
| Mylan | 17.90B |
| Endo Health Solutions | 6.581B |
| Warner Chilcott | 8.417B |
IPXL Enterprise Value Rankings
| Overall |
72nd percentile 2174 of 8002 |
| Sector |
73rd percentile 181 of 684 in Healthcare |
| Industry |
70th percentile 20 of 68 in Drug Manufacturers - Specialty & Generic |
IPXL Enterprise Value Range, Past 5 Years
| Minimum | 50.46M | Jan 14 2009 |
| Maximum | 1.526B | May 10 2011 |
| Average | 879.37M |
IPXL News
Street Insider May 10